Effects of modafinil on cognitive performance and alertness during sleep deprivation

Current Pharmaceutical Design

Volumn 12, Issue 20, 2006, Pages 2457-2471

  Wesensten, Nancy J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Alertness; Executive function; Modafinil; Reaction time; Sleep deprivation; Stimulants

Indexed keywords

ADRAFINIL; AMPHETAMINE; CAFFEINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; MODAFINIL; PLACEBO;

AEROSPACE MEDICINE; AGGRESSIVENESS; ALERTNESS; ANOREXIA; ANXIETY DISORDER; APTITUDE TEST; AROUSAL; ASSOCIATIVE MEMORY; BRAIN FUNCTION; CIRCADIAN RHYTHM; CLINICAL TRIAL; COGNITION; CONFUSION; COORDINATION DISORDER; DIZZINESS; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EUPHORIA; EVIDENCE BASED MEDICINE; FATIGUE; FUNCTIONAL ASSESSMENT; GOLD STANDARD; HALLUCINATION; HEART PALPITATION; HEARTBURN; HUMAN; INTERMETHOD COMPARISON; IRRITABILITY; LATENT PERIOD; LONG TERM MEMORY; LOW DRUG DOSE; MOOD DISORDER; MOTIVATION; MUSCLE TONE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECALL; REVIEW; SEXUALITY; SHIFT WORKER; SHORT TERM MEMORY; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP TIME; SPEECH DISORDER; SYMPTOM CHECKLIST 90; SYSTEMATIC REVIEW; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT OUTCOME; URINARY FREQUENCY; VERTIGO; VISUAL ANALOG SCALE; VISUAL MEMORY; WAKEFULNESS; WORKING MEMORY;

AROUSAL; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PSYCHOMOTOR PERFORMANCE; SLEEP DEPRIVATION; SLEEP DISORDERS;

EID: 33745738094     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206777698819     Document Type: Review

References (60)

1. Moachon G, Kanmacher I, Clenet M, Matinier D. Pharmacokinetic profile of modafinil. Drugs Today 1996; 32: 327-37.
2. Fuxe K, Rambert FA, Ferraro L, O'Connor W, Laurent Ph, Agnati LF, et al. Preclinical studies with modafinil. Evidence for vigilance enhancement and neuroprotection. Drugs Today 1996; 32: 313-26.
3. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21: 1787-94
4. Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K. The effects of modafinil on striatal, pallidal, and negral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett 1998; 253: 135-8.
5. Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J, et al. The vigilance-promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharm 1999; 20: 346-56.
6. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neuroscience 2000; 22: 8620-8.
7. Ishizuka. T, Sakamoto Y, Sakurai T, Yamatodani A. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 2003; 339: 143-6.
8. Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 2004; 27: 19-25.
9. Saper CB, Scammell TE. Modafinil: a drug in search of a mechanism. Sleep 2004:27: 11-2.
10. Wilkinson RT. In: Edholm OG, Bacharach AL Eds, The Physiology of Human Survival. London, Academic Press 1965; 399-430.
11. Dinges DF, Powell JW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Meth Instr CoMp 1985; 17: 652-5.
12. Bensimon G, Benoit D, Lacomblez L, Weiller E, Warot D, Weil JS, et al. Antagonism by modafinil of the psychomotor and cognitive impairment induced by sleep-deprivation in 12 healthy volunteers. Eur Psychiatry 1991; 6: 93-7.
13. Saletu B, Grunberger J, Linzmayer L, Stohr H. Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (adrafanil) in elderlies. New Trends Exp Clin Psychiatry 1986; 2: 5-31.
14. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj MJ. Differential effects of a new central adrenergic agonist - modafinil - and D-amphetamine on sleep and early morning behavior in young healthy volunteers. Int J Clin Pharmacol Res 1989; 9: 183-95.
15. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212-28.
16. Pigeau RA, Angus RG. In: Friedl K, Lieberman H, Ryan DH, Bray GA Eds, Countermeasures for Battlefield Stressors. Baton Rouge, Louisiana State University Press 2000; 206-27.
17. Baranski JV, Gil V, McLellan TM, Moroz D, Buguet A, Radomski M. Effects of modafinil on cognitive performance during 40 hours of sleep deprivation in a warm environment. Mil Psychol 2002; 14: 23-47.
18. Lagarde D, Batejat D. Some measures to reduce effects of prolonged sleep deprivation. Neurophysiol Clin 1995; 25: 376-85.
19. Batejat DM, Lagarde DP. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviat Space Environ Med 1999; 70: 493-8.
20. Lagarde D, Batejat D, Van Beers P, Sarafian D, Pradella S. Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fundam Clin Pharmacol 1995; 9: 271-9.
21. Brun J, Chamba G, Khalfallah Y, Girard P, Boissy I, Bastuji H, et al. Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J Sleep Res 1998; 7: 105-14.
22. Stivalet P, Esquivie D, Barraud P-A, Leifflen D, Raphel C. Effects of modafinil on attentional processes during 60 hours of sleep deprivation. Hum Psychopharmacol Clin Exp 1998; 13: 501-7.
23. Caldwell JA, Caldwell JL, Smythe NK, Hall KK. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl) 2000; 150: 272-82.
24. Caldwell JA, Caldwell JL, Smith JK, Brown DL. Modafinil's effects on simulator performance and mood in pilots during 37 h without sleep. Aviat Space Environ Med 2004; 75: 777-85.
25. Walsh JK, Randazzo AC, Stone KL, Schweitzer PK. Modafinil improves alertness, vigilance, and executive function during simulated night shifts. Sleep 2004; 27: 434-9.
26. Wesensten N, Killgore W, Balkin T. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 2005; 14: 255-66.
27. Baranski JV, Pigeau R, Dinish P, Jacobs I. Effects of modafinil on cognitive and meta-cognitive performance. Hum Psychopharm 2004; 19: 323-32.
28. Baranski JV, Cian C, Esquivie D, Pigeau RA, Raphel C. Modafinil during 64 hr of sleep deprivation: dose-related effects on fatigue, alertness, and cognitive performance. Mil Psychol 1998; 10: 173-93.
29. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl) 2002; 159: 238-47.
30. Harrison Y, Horne JA. Sleep loss impairs short and novel language tasks having a prefrontal focus. J Sleep Res 1998; 7: 95-100.
31. Harrison Y, Horne JA. One night of sleep loss impairs innovative thinking and flexible decision making. Organ Behav Hum Decis Process 1999; 78: 128-45.
32. Thomas M, Sing H, Belenky G, Holcomb H, Mayberg H, Dannals R, el al. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res 2000; 9: 335-52.
33. Bard EG, Sotillo C, Anderson AH, Thompson HS, Taylor MM. The DCIEM Map Task Corpus: spontaneous dialogue under sleep deprivation and drug treatment. Speech Commun 1996, 20: 71-84.
34. Baranski JV, Pigeau. RA. Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. J Sleep Res 1997; 6: 84-91.
35. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 2003; 165: 260-9.
36. Randall DC, Fleck NL, Shneerson JM, File SE. The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav 2004; 77: 547-55.
37. Muller U, Steffenhagen N, Regenthal R, Bublak P. Effects of modafinil on working memory processes in humans. Psychopharmacology 2004; 177: 161-9.
38. Randall DC, Shneerson JM, Plaha KK, File SE. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 2003; 18: 163-73.
39. Bonnet MH, Arand DL. Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev 2003; 7: 297-310.
40. Richardson GS, Carskadon MA, Flagg W, van den Hoed J, Dement WC, Mittler MM. Excessive daytime sleepiness in man: multiple sleep latency test measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978; 45: 621-7.
41. Hartse KM, Roth T, Zorick FJ. Daytime sleepiness and daytime wakefulness: the effect of instruction. Sleep 1982; 5(Suppl 2): S107-18.
42. Mitler MM, Gujavarty KS, Browman CP. Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 1982; 53: 658-61.
43. Carskadon MA, Dement WC. Cumulative effects of sleep restriction on daytime sleepiness. Pachophysiology 1981; 18: 107-13.
44. Mitler M, Miller JC. Methods of testing for sleepiness. Behav Med 1996; 21: 171-83.
45. Stampi C, Michimori A, Aguirre A, Stone P. A new quantitative method for the objective assessment of sleepiness: the alpha attenuation test. J Sleep Res 1994; 3 suppl 1: 240.
46. Chapotot F, Pigeau R, Canini F, Bourdon L, Buguet A. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG. Psychopharmacology (Berl) 2003; 166: 127-38.
47. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431-6.
48. Akersiedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci 1990; 52: 29-37.
49. Johns M. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-5.
50. McNair D, Lorr M, Droppleman L. Profile of Mood States Manual. San Diego, Educational & Industrial Testing Services. 1971.
51. Warot D, Corruble E, Payan C, Weil JS, Puech AJ. Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur Psychiat 1993; 8: 201-8.
52. Buguet A, Montmayeur A, Pigeau R, Naitoh P. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep. J Sleep Res 1995; 4: 229-241.
53. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj MJ. Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behavior in elderlies. Arzniem-Forsch / Drug Res 1989; 39: 1268-73.
54. Newhouse PA, Belenky G, Thomas M, Thorne D, Sing HC, Fertig J. The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation. Neuropsychopharmacol 1989; 2: 153-64.
55. Penetar D, McCann U, Thorne D, Kamimori G, Galinski C, Sing H, et al. Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology 1993; 112: 359-65.
56. Launay JC, Besnard Y, Guinet A, Bessard G, Raphel C, Savourey G. Effects of modafinil on heat thermoregulatory responses in humans at rest. Can J Physiol Pharmacol 2002; 80: 796-803.
57. McLellan TM, Ducharme MB, Canini F, Moroz D, Bell DG, Baranski JV, et al. Effect of modafinil on core temperature during sustained wakefulness and exercise in a warm environment. Aviat Space Environ Med 2002; 73: 1079-88.
58. Frolich L, Fox J, Padberg F, Maurer K, Moller HJ, Hampel H. Targets of antidementive therapy: drugs with a specific pharmacological mechanism of action. Curr Pharm Des 2004; 10(3): 223-9.
59. Johnston GA. GABA(A) receptor channel pharmacology. Curr Pharm Des 2005; 11(15): 1867-85.
60. Selimoglu E. Nitric oxide in health and disease from the point of view of the otorhinolaryngologist. Curr Pharm Des 2005; 11(23): 3051-60.